1. Home
  2. News
  3. NATCO Pharma Limited
  4. Press Release Dec 17 2020
More NATCO Pharma Limited news
NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Dec 17 2020

Dec 17, 2020 at 2:28 PM EST · Issued by NATCO Pharma Limited

Filed with NSE · Dec 17, 2020 at 2:28 PM EST · 2 pages · English

On 6ix: 6ix.com/news/press-release-dec-17-2020-4

Watch NATCO Pharma's latest callNATCO Pharma (NSE:NATCOPHARM) Q2 2027 Earnings Call · Replay · Nov 13↗

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

  • NATCO Pharma receives Pomalidomide approval for US marketNov 16, 2020
  • Press Release Nov 13 2020Nov 13, 2020
  • Press Release Nov 12 2020Nov 12, 2020
  • Press Release Sep 30 2020Sep 30, 2020
  • NATCO Pharma records INR 582.1 Crore consolidated revenue and INR 122.1 Crore of profit, after tax, for the First Quarter, FY2020-21Aug 13, 2020

Later from NATCO Pharma

  • NATCO Pharma launches anti blood clot tablet Rivaroxaban in IndiaDec 18, 2020
  • Press Release Feb 05 2021Feb 5, 2021
  • NATCO Pharma receives approval for Chlorantraniliprole 1st key product of Crop Health Sciences DivisionFeb 8, 2021
  • Press Release Feb 26 2021Feb 26, 2021
  • NATCO Pharma launches Brivaracetam tablets, in India, for treatment of epilepsyMar 1, 2021
All NATCO Pharma news releases↗

Follow NATCO Pharma into a list and get an email when it puts out news.

Follow NATCO Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer